Plavix

[Clopidogrel]

Autonomic Nervous System Disorders

Syncope, Palpitation.

Body as a Whole-general disorders: Asthenia, Fever, Hernia.

Text Continues Below

---

Cardiovascular disorders

Cardiac failure.

Central and peripheral nervous system disorders

Cramps legs, Hypoaesthesia, Neuralgia, Paraesthesia, Vertigo.

Gastrointestinal system disorders

Constipation, Vomiting.

Heart rate and rhythm disorders

Fibrillation atrial. Liver and biliary system disorders

Hepatic enzymes increased.

Metabolic and nutritional disorders

Gout, hyperuricemia, non-protein nitrogen (NPN) increased.

Musculo-skeletal system disorders

Arthritis, Arthrosis.

Platelet, bleeding & clotting disorders

GI hemorrhage, hematoma, platelets decreased.

Psychiatric disorders: Anxiety, Insomnia.

Red blood cell disorders

Anemia.

Respiratory system disorders

Pneumonia, Sinusitis.

Skin and appendage disorders

Eczema, Skin ulceration.

Urinary system disorders

Cystitis.

Vision disorders

Cataract, Conjunctivitis.

Other potentially serious adverse events which may be of clinical interest but were rarely reported (<1%) in patients who received PLAVIX in the CAPRIE or CURE controlled clinical trials are listed below regardless of relationship to PLAVIX. In general, the incidence of these events was similar to that in patients receiving aspirin (in CAPRIE) or placebo + aspirin (in CURE).

Body as a whole

Allergic reaction, necrosis ischemic.

Cardiovascular disorders

Edema generalized.

Gastrointestinal system disorders

Gastric ulcer perforated, gastritis hemorrhagic, upper GI ulcer hemorrhagic.

Liver and Biliary system disorders

Bilirubinemia, hepatitis infectious, liver fatty.

Platelet, bleeding and clotting disorders

hemarthrosis, hematuria, hemoptysis, hemorrhage intracranial, hemorrhage retroperitoneal, hemorrhage of operative wound, ocular hemorrhage, pulmonary hemorrhage, purpura allergic, thrombocytopenia.

Page:  << Prev | 1 | 2 | 3 | 4 | 5 | Next >>